PriMera Scientific Surgical Research and Practice (ISSN: 2836-0028)

Mini-Review

Volume 7 Issue 6

A Balanced Analysis: Risks Vs Benefits of Estrogen Replacement Therapy

Apoorva Kamboj* and Shashi Joshi

May 30, 2026

DOI : 10.56831/PSSRP-07-270

View PDF

Abstract

As women age, there is a large increase in the incidence of stroke which has been observed in a number of cases. There is an increased interest in risks and benefits of HRT in females who are  at-risk to CVD and stroke and for this estrogen has been studied in particular. But only limited data of trends is available and hence still the question of ERT to be used for prevention of CHD & stroke remains unanswered.

References

  1. Nachtigall LE., et al. “Estrogen replacement therapy. II. A prospective study in the relationship to carcinoma and cardiovascular and metabolic problems”. Obstet Gynecol 54 (1979): 74-79.
  2. Talbott E, Kuller LH and Detre K. “Biologic and psychosocial risk factors of sudden death from coronary heart disease in white women”. Am J Cardiol 39 (1977): 858-864.
  3. Ross RK., et al. “Menopausal oestrogen therapy and protection from death from ischaemic heart disease”. Lancet 8225 (1981): 858-860.
  4. Szklo M., et al. “Estrogen use and myocardial infarction risk: a case-control study”. Prev Med 13 (1984): 510-516.
  5. Adam S, Williams V and Vesey MP. “Cardiovascular disease and hormone replacement: a pilot case-control study”. Br Med J 282 (1981): 1277-1278.
  6. Pfeffer RI., et al. “Coronary risk and estrogen use in postmenopausal women”. Am J Epidemiol 107 (1978): 479-487.
  7. Rosenberg L, Armstrong B and Jick J. “Myocardial infarction and estrogen therapy in postmenopausal women”. N Engl J Med 294 (1976): 1256-1259.
  8. Rosenberg L., et al. “Noncontraceptive estrogens and myocardial infarction in young women”. JAMA 244 (1980): 339-342.
  9. Jick J, Dinan B and Rothman KJ. “Noncontraceptive estrogens and nonfatal myocardial infarction”. JAMA 239 (1978): 1407-1408.
  10. Lafferty FW and Helmuth DO. “Postmenopausal estrogen replacement: the prevention of osteoporosis and systemic effects”. Maturitas 7 (1985): 137-159.
  11. MacMahon B. “Cardiovascular disease and noncontraceptive oestrogen therapy. In Coronary heart disease in young women, edited by Oliver”. Churchill Livingstone, New York (1978): 197-207.
  12. Stampfer MJ., et al. “A prospective study of postmenopausal estrogen therapy and coronary heart disease”. N Engl J Med 313 (1985): 1044-1049.
  13. Hammond CB., et al. “Effects of long-term estrogen replacement therapy. I. Metabolic effects”. Am J Obstet Gynecol 133 (1979): 525-536.
  14. Potocki J. “The Effect of Estrogen Therapy on Coronary Insufficiency in Postmenopausal Women”. Pol Tyg Lek 26 (1971): 1812-1815.
  15. Bush TL., et al. “Cardiovascular mortality and noncontraceptive estrogen use in women: results from the Lipid Research Clinics Program Follow-up Study”. Cir 75 (1987): 1102-1109.
  16. Burch JC, Byrd BF, Jr and Vaughn WK. “The effects of long-term estrogen on hysterectomized women”. Am J Obstet Gynecol 118 (1974): 778-782.
  17. Petitti DB, Perlman JA and Sidney S. “Postmenopausal estrogen use and heart disease”. N Engl J Med 315 (1986): 131-132.
  18. Henderson BE., et al. “Estrogen use and cardiovascular disease”. Am J Obstet Gynecol 154 (1986): 1181-1186.
  19. Wilson PWF, Garrison RJ and Castelli WP. “Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50”. N Engl J Med 313 (1985): 1038-1043.
  20. Vogel K and Seladi-Schulman J. “Estrogen: How lifelong exposure may reduce the risk of stroke”. Healthline.
  21. Hurn PD and Macrae IM. “Estrogen as neuroprotectant in stroke”. J Cereb Blood Flow Metab 20 (2023): 631-652.
  22. Garcia-Segura LM, Azcoitia I and DonCarlos LL. “Neuroprotection by estradiol. Prog Neurobiol 63 (2001): 29-60.
  23. Green PS and Simpkins JW. Neuroprotective effects of estrogens: potential mechanisms of action”. Int J Dev Neuroscience 18 (2000): 347-358.
  24. Wise PM., et al. “Estradiol is a protective factor in the adult and aging brain”. Brain Res Rev 37 (2001): 313-319.
  25. Hurn PD and Brass LM. “Estrogen and stroke: a balanced analysis”. Stroke 34.2 (2003): 338-341.
  26. Grodstein F and Stampfer MJ. “The epidemiology of coronary heart disease and estrogen replacement in postmenopausal women”. Prog Cardiovasc Dis 38 (1995): 199-210.
  27. Barrett-Connor E and Grady D. “Hormone replacement therapy, heart disease, and other considerations”. Ann Rev Public Health 19 (1998): 55-72.
  28. Grady D., et al. “Hormone therapy to prevent disease and prolong life in postmenopausal women”. Ann Intern Med 117 (1992): 1016-1037.
  29. Stampfer MJ and Colditz GA. “Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiological evidence”. Prev Med 20 (1991): 47-63.
  30. Sullivan JM., et al. “Estrogen replacement and coronary artery disease: effect on survival in postmenopausal women”. Arch Intern Med 150 (1990): 2557-2561.
  31. Collins J., et al. “Oestrogen use and survival in endometrial cancer”. Lancet 8201 (1980): 961-964.
  32. Brinton LA, Hoover R and Fraumeni JF Jr. “Menopausal oestrogens and breast cancer risk: an expanded case-control study”. Br J Cancer 54 (1986): 825-832.
  33. Wingo PA., et al. “The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy”. JAMA 257.2 (1987): 209-215.